Trials
Search / Trial NCT05649202

Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Dec 10, 2022

Trial Information

Current as of February 05, 2025

Not yet recruiting

Keywords

Hepatitis C Daa Hcv Viral Test Liver Fibrosis

ClinConnect Summary

Detainees have specific health needs due to the high prevalence of several pathologies (HIV, HCV, tuberculosis, chronic diseases, addictions, psychiatric disorders associated in some cases with suicide attempts, etc.) and a degraded state of health. Detainees are frequently from the most disadvantaged social groups with low use of the health system prior to incarceration (drug users, people in precarious situations, migrants).

Although there is no data available in France about the incidence of HCV on inmates, several studies in France have documented exposure to the risk of transmission o...

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Adult patient (\>/= 18 years old),
  • Persons detained at the Paris-La Santé Penitentiary Center (CPPLS) coming from the state of freedom or transferred from another penitentiary establishment
  • Serology HCV positive
  • Exclusion Criteria:
  • Major psychiatric disorders with loss of discernment
  • Persons under guardianship or curatorship
  • Persons not affiliated to a social security scheme

Trial Officials

Benjamin ANDREW SILBERMANN, MsD

Principal Investigator

APHP

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials